A phase 1 multiple‐ascending dose study of tirzepatide in Japanese participants with type 2 diabetes

AIM: To investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of tirzepatide in Japanese participants with type 2 diabetes (T2D). METHODS: This phase 1, double‐blind, placebo‐controlled, parallel‐dose, multiple‐ascending dose study randomized participants to once‐wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Furihata, Kenichi, Mimura, Hanaka, Urva, Shweta, Oura, Tomonori, Ohwaki, Kenji, Imaoka, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299227/
https://www.ncbi.nlm.nih.gov/pubmed/34647404
http://dx.doi.org/10.1111/dom.14572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299227/
https://www.ncbi.nlm.nih.gov/pubmed/34647404
http://dx.doi.org/10.1111/dom.14572

Ejemplares similares